MicroRNA expression in hepatitis C virus-related malignancies: A brief review

World Journal of Gastroenterology

Volumn 21, Issue 28, 2015, Pages 8562-8568

  Gragnani, Laura ^a   Piluso, Alessia ^a   Fognani, Elisa ^a   Zignego, Anna Linda ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Hepatitis C virus; Hepatocellular carcinoma; Lymphoma; MicroRNA

Indexed keywords

MICRORNA; TUMOR MARKER;

CHRONIC HEPATITIS C; GENE EXPRESSION; HEPATITIS C VIRUS; HUMAN; IN VITRO STUDY; LIVER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LYMPHOMA; NONHUMAN; PATHOGENESIS; REVIEW; VIRUS ETIOLOGY; ANIMAL; COMPLICATION; GENE EXPRESSION REGULATION; GENETICS; HEPACIVIRUS; HEPATITIS C; HOST PATHOGEN INTERACTION; LIVER TUMOR; NONHODGKIN LYMPHOMA; PATHOGENICITY; PATHOLOGY; VIROLOGY; VIRUS CELL TRANSFORMATION;

ANIMALS; BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, VIRAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPACIVIRUS; HEPATITIS C; HOST-PATHOGEN INTERACTIONS; HUMANS; LIVER NEOPLASMS; LYMPHOMA, NON-HODGKIN; MICRORNAS;

EID: 84937887929     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i28.8562     Document Type: Review

References (45)

1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of agespecific antibody to HCV seroprevalence. Hepatology 2013; 57: 1333-1342 [PMID: 23172780 DOI: 10.1002/hep.26141]
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID: 21296855 DOI: 10.3322/caac.20107]
3. Zignego AL, Giannini C, Gragnani L. HCV and lymphoproliferation. Clin Dev Immunol 2012; 2012: 980942 [PMID: 22852020 DOI: 10.1155/2012/980942]
4. McGivern DR, Lemon SM. Tumor suppressors, chromosomal instability, and hepatitis C virus-associated liver cancer. Annu Rev Pathol 2009; 4: 399-415 [PMID: 18928409 DOI: 10.1146/annurev.pathol.4.110807.092202]
5. Peveling-Oberhag J, Arcaini L, Hansmann ML, Zeuzem S. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management. J Hepatol 2013; 59: 169-177 [PMID: 23542089 DOI: 10.1016/j.jhep.2013.03.018]
6. Inui M, Martello G, Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 2010; 11: 252-263 [PMID: 20216554 DOI: 10.1038/nrm2868]
7. Zhang L, Coukos G. MicroRNAs: a new insight into cancer genome. Cell Cycle 2006; 5: 2216-2219 [PMID: 17012848 DOI: 10.4161/cc.5.19.3319]
8. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005; 309: 1577-1581 [PMID: 16141076 DOI: 10.1126/science.1113329]
9. Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, van der Meer AJ, Patick AK, Chen A, Zhou Y, Persson R, King BD, Kauppinen S, Levin AA, Hodges MR. Treatment of HCV infection by targeting microRNA. N Engl J Med 2013; 368: 1685-1694 [PMID: 23534542 DOI: 10.1056/NEJMoa1209026]
10. Wilson JA, Zhang C, Huys A, Richardson CD. Human Ago2 is required for efficient microRNA 122 regulation of hepatitis C virus RNA accumulation and translation. J Virol 2011; 85: 2342-2350 [PMID: 21177824 DOI: 10.1128/JVI.02046-10]
11. Gebert LF, Rebhan MA, Crivelli SE, Denzler R, Stoffel M, Hall J. Miravirsen (SPC3649) can inhibit the biogenesis of miR-122. Nucleic Acids Res 2014; 42: 609-621 [PMID: 24068553 DOI: 10.1093/nar/gkt852]
12. Wilson JA, Sagan SM. Hepatitis C virus and human miR-122: insights from the bench to the clinic. Curr Opin Virol 2014; 7: 11-18 [PMID: 24721497 DOI: 10.1016/j.coviro.2014.03.005]
13. Wang Y, Kato N, Jazag A, Dharel N, Otsuka M, Taniguchi H, Kawabe T, Omata M. Hepatitis C virus core protein is a potent inhibitor of RNA silencing-based antiviral response. Gastroenterology 2006; 130: 883-892 [PMID: 16530526 DOI: 10.1053/j.gastro.2005.12.028]
14. Varnholt H, Drebber U, Schulze F, Wedemeyer I, Schirmacher P, Dienes HP, Odenthal M. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 2008; 47: 1223-1232 [PMID: 18307259 DOI: 10.1002/hep.22158]
15. Elfimova N, Sievers E, Eischeid H, Kwiecinski M, Noetel A, Hunt H, Becker D, Frommolt P, Quasdorff M, Steffen HM, Nürnberg P, Büttner R, Teufel A, Dienes HP, Drebber U, Odenthal M. Control of mitogenic and motogenic pathways by miR-198, diminishing hepatoma cell growth and migration. Biochim Biophys Acta 2013; 1833: 1190-1198 [PMID: 23391410 DOI: 10.1016/j.bbamcr.2013.01.023]
16. Ishida H, Tatsumi T, Hosui A, Nawa T, Kodama T, Shimizu S, Hikita H, Hiramatsu N, Kanto T, Hayashi N, Takehara T. Alterations in microRNA expression profile in HCV-infected hepatoma cells: involvement of miR-491 in regulation of HCV replication via the PI3 kinase/Akt pathway. Biochem Biophys Res Commun 2011; 412: 92-97 [PMID: 21802413 DOI: 10.1016/j.bbrc.2011.07.049]
17. Liu X, Wang T, Wakita T, Yang W. Systematic identification of microRNA and messenger RNA profiles in hepatitis C virusinfected human hepatoma cells. Virology 2010; 398: 57-67 [PMID: 20006370 DOI: 10.1016/j.virol.2009.11.036]
18. Salvi A, Abeni E, Portolani N, Barlati S, De Petro G. Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/noncirrhotic HCC. Int J Oncol 2013; 42: 391-402 [PMID: 23229173 DOI: 10.3892/ijo.2012.1716]
19. Braconi C, Valeri N, Gasparini P, Huang N, Taccioli C, Nuovo G, Suzuki T, Croce CM, Patel T. Hepatitis C virus proteins modulate microRNA expression and chemosensitivity in malignant hepatocytes. Clin Cancer Res 2010; 16: 957-966 [PMID: 20103677 DOI: 10.1158/1078-0432.CCR-09-2123]
20. Niketeghad F, Decker HJ, Caselmann WH, Lund P, Geissler F, Dienes HP, Schirmacher P. Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis. Br J Cancer 2001; 85: 697-704 [PMID: 11531255 DOI: 10.1054/bjoc.2001.1963]
21. Kusano N, Okita K, Shirahashi H, Harada T, Shiraishi K, Oga A, Kawauchi S, Furuya T, Sasaki K. Chromosomal imbalances detected by comparative genomic hybridization are associated with outcome of patients with hepatocellular carcinoma. Cancer 2002; 94: 746-751 [PMID: 11857308]
22. Abdalla MA, Haj-Ahmad Y. Promising Candidate Urinary MicroRNA Biomarkers for the Early Detection of Hepatocellular Carcinoma among High-Risk Hepatitis C Virus Egyptian Patients. J Cancer 2012; 3: 19-31 [PMID: 22211142 DOI: 10.7150/jca.3.19]
23. Diaz G, Melis M, Tice A, Kleiner DE, Mishra L, Zamboni F, Farci P. Identification of microRNAs specifically expressed in hepatitis C virus-associated hepatocellular carcinoma. Int J Cancer 2013; 133: 816-824 [PMID: 23390000 DOI: 10.1002/ijc.28075]
24. Chen JS, Wang Q, Fu XH, Huang XH, Chen XL, Cao LQ, Chen LZ, Tan HX, Li W, Bi J, Zhang LJ. Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9. Hepatol Res 2009; 39: 177-186 [PMID: 19208038 DOI: 10.1111/j.1872-034X.2008.00449.x]
25. Hsu HC, Tseng HJ, Lai PL, Lee PH, Peng SY. Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumor growth and invasiveness. Cancer Res 1993; 53: 4691-4694 [PMID: 8402647 DOI: 10.1.1.326.2618]
26. Huang S, He X, Ding J, Liang L, Zhao Y, Zhang Z, Yao X, Pan Z, Zhang P, Li J, Wan D, Gu J. Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. Int J Cancer 2008; 123: 972-978 [PMID: 18508316 DOI: 10.1002/ijc.23580]
27. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T, Shimotohno K. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006; 25: 2537-2545 [PMID: 16331254 DOI: 10.1038/sj.onc.1209283]
28. Ura S, Honda M, Yamashita T, Ueda T, Takatori H, Nishino R, Sunakozaka H, Sakai Y, Horimoto K, Kaneko S. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 2009; 49: 1098-1112 [PMID: 19173277 DOI: 10.1002/hep.22749]
29. Shirasaki T, Honda M, Shimakami T, Horii R, Yamashita T, Sakai Y, Sakai A, Okada H, Watanabe R, Murakami S, Yi M, Lemon SM, Kaneko S. MicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cells. J Virol 2013; 87: 5270-5286 [PMID: 23449803 DOI: 10.1128/JVI.03022-12]
30. Bouteloup M, Verney A, Rachinel N, Callet-Bauchu E, Ffrench M, Coiffier B, Magaud JP, Berger F, Salles GA, Traverse-Glehen A. MicroRNA expression profile in splenic marginal zone lymphoma. Br J Haematol 2012; 156: 279-281 [PMID: 21902683 DOI: 10.1111/j.1365-2141.2011.08848.x]
31. Di Lisio L, Martinez N, Montes-Moreno S, Piris-Villaespesa M, Sanchez-Beato M, Piris MA. The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas. Blood 2012; 120: 1782-1790 [PMID: 22760782 DOI: 10.1182/blood-2012-05-402784]
32. Peveling-Oberhag J, Crisman G, Schmidt A, Döring C, Lucioni M, Arcaini L, Rattotti S, Hartmann S, Piiper A, Hofmann WP, Paulli M, Küppers R, Zeuzem S, Hansmann ML. Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection. Leukemia 2012; 26: 1654-1662 [PMID: 22307176 DOI: 10.1038/leu.2012.29]
33. Fognani E, Giannini C, Piluso A, Gragnani L, Monti M, Caini P, Ranieri J, Urraro T, Triboli E, Laffi G, Zignego AL. Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemia. PLoS One 2013; 8: e62965 [PMID: 23650540 DOI: 10.1371/journal.pone.0062965]
34. Gragnani L, Fognani E, Piluso A, Zignego AL. Hepatitis C-associated B-cell non-Hodgkin lymphomas: the emerging role of miRNA-26b. J Hepatol 2013; 59: 1362-1363 [PMID: 23978716 DOI: 10.1016/j.jhep.2013.07.045]
35. van den Berg A, Kroesen BJ, Kooistra K, de Jong D, Briggs J, Blokzijl T, Jacobs S, Kluiver J, Diepstra A, Maggio E, Poppema S. High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma. Genes Chromosomes Cancer 2003; 37: 20-28 [PMID: 12661002 DOI: 10.1002/gcc.10186]
36. Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, Jacobs S, Kroesen BJ, van den Berg A. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 2005; 207: 243-249 [PMID: 16041695 DOI: 10.1002/path.1825]
37. Li S, Liang Z, Xu L, Zou F. MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases. Mol Cell Biochem 2012; 360: 147-158 [PMID: 21909994 DOI: 10.1007/s11010-011-1052-6]
38. Bruni R, Marcantonio C, Pulsoni A, Tataseo P, De Angelis F, Spada E, Marcucci F, Panfilio S, Bianco P, Riminucci M, Villano U, Tosti M, Ciccaglione A, Mele A. microRNA levels in paraffinembedded indolent B-cell non-Hodgkin lymphoma tissues from patients chronically infected with hepatitis B or C virus. BMC Infect Dis 2014; 14 Suppl 5: S6 [PMID: 25236768 DOI: 10.1186/1471-2334-14-S5-S6]
39. Augello C, Gianelli U, Savi F, Moro A, Bonoldi E, Gambacorta M, Vaira V, Baldini L, Bosari S. MicroRNA as potential biomarker in HCV-associated diffuse large B-cell lymphoma. J Clin Pathol 2014; 67: 697-701 [PMID: 24914240 DOI: 10.1136/jclinpath-2014-202352]
40. Monleau M, Bonnel S, Gostan T, Blanchard D, Courgnaud V, Lecellier CH. Comparison of different extraction techniques to profile microRNAs from human sera and peripheral blood mononuclear cells. BMC Genomics 2014; 15: 395 [PMID: 24885883 DOI: 10.1186/1471-2164-15-395]
41. McAlexander MA, Phillips MJ, Witwer KW. Comparison of Methods for miRNA Extraction from Plasma and Quantitative Recovery of RNA from Cerebrospinal Fluid. Front Genet 2013; 4: 83 [PMID: 23720669 DOI: 10.3389/fgene.2013.00083]
42. Linsen SE, de Wit E, Janssens G, Heater S, Chapman L, Parkin RK, Fritz B, Wyman SK, de Bruijn E, Voest EE, Kuersten S, Tewari M, Cuppen E. Limitations and possibilities of small RNA digital gene expression profiling. Nat Methods 2009; 6: 474-476 [PMID: 19564845 DOI: 10.1038/nmeth0709-474]
43. Jayaprakash AD, Jabado O, Brown BD, Sachidanandam R. Identification and remediation of biases in the activity of RNA ligases in small-RNA deep sequencing. Nucleic Acids Res 2011; 39: e141 [PMID: 21890899 DOI: 10.1093/nar/gkr693]
44. Zhang Z, Lee JE, Riemondy K, Anderson EM, Yi R. Highefficiency RNA cloning enables accurate quantification of miRNA expression by deep sequencing. Genome Biol 2013; 14: R109 [PMID: 24098942 DOI: 10.1186/gb-2013-14-10-r109]
45. Sorefan K, Pais H, Hall AE, Kozomara A, Griffiths-Jones S, Moulton V, Dalmay T. Reducing ligation bias of small RNAs in libraries for next generation sequencing. Silence 2012; 3: 4 [PMID: 22647250 DOI: 10.1186/1758-907X-3-4]